Boston Scientific Corp (BSX) Financials

$47.80

$0.85 (1.81%)

As on 04-Sep-2026 16:15EDT

Market cap

$68,041 Mln

Revenue (TTM)

$20,996 Mln

P/E Ratio

19.6

P/B Ratio

2.8

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	20,996.00	20,074.00	16,747.00	14,240.00	12,682.00	11,888.00
Cost of Revenue	6,055.00	6,221.00	6,480.00	5,409.00	4,968.00	4,427.00
Gross Profit	14,940.00	13,853.00	10,267.00	8,831.00	7,714.00	7,461.00
Operating Expenses	10,434.00	9,882.00	7,632.00	6,650.00	5,890.00	5,539.00
Operating Profit (EBIT)	4,506.00	3,971.00	2,635.00	2,181.00	1,824.00	1,922.00
Other Income	--	--	--	--	-38.00	218.00
Profit before Tax	3,861.00	3,385.00	2,282.00	1,985.00	1,141.00	1,076.00
Provision for Tax	193.00	493.00	436.00	393.00	443.00	36.00
Profit after Tax (Net Income)	3,667.00	2,886.00	1,854.00	1,593.00	698.00	1,040.00
Minority Interest	6.00	6.00	8.00	1.00	--	--
Consolidated Profit	1,427.00	2,898.00	1,853.00	1,570.00	642.00	986.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	24,930.00	24,233.00	21,770.00	19,282.00	17,574.00	16,623.00
Minority Interest	6.00	--	--	--	--	--
Non-Current Liabilities	13,616.00	13,762.00	10,993.00	10,673.00	11,093.00	11,333.00
Current Liabilities	6,428.00	5,439.00	6,399.00	4,933.00	3,803.00	4,274.00
Total Liabilities	51,644.00	43,673.00	39,395.00	35,136.00	32,470.00	32,230.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	37,243.00	34,879.00	32,476.00	28,622.00	26,710.00	25,911.00
Current Assets	7,972.00	8,794.00	6,920.00	6,514.00	5,760.00	6,317.00
Total Assets	51,644.00	43,673.00	39,395.00	35,136.00	32,470.00	32,230.00
Total Debt*	12,624.00	12,418.00	11,147.00	9,492.00	9,282.00	9,451.00
Net Current Assets	1,544.00	3,355.00	521.00	1,581.00	1,957.00	2,043.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	4,534.00	3,435.00	2,503.00	1,526.00	1,870.00
Cash Flow from Investing Activities	--	-2,640.00	-5,687.00	-2,574.00	-2,011.00	-1,597.00
Cash from Financing Activities	--	-395.00	1,814.00	5.00	-548.00	-95.00
Net Cash Inflow / Outflow	--	--	--	--	-1,033.00	178.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	2.46	1.93	1.24	1.08	0.48	0.72
Cash EPS ($)	2.40	2.84	2.10	1.88	1.04	1.24
Adjusted Book Value ($)	17.23	16.20	14.61	13.06	12.18	11.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	3.03	2.31	1.69	1.06	1.30
Free Cash Flow per Share ($)	--	2.45	1.77	1.15	0.63	0.92

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	8.30	6.01	5.73	2.64	4.08
ROE (%)	14.94	12.55	9.03	8.64	4.08	6.51
ROA (%)	7.45	6.95	4.98	4.71	2.16	3.30
EBIT Margin (%)	20.12	18.60	15.94	15.85	12.66	11.99
Net Margin (%)	17.47	14.38	11.07	11.19	5.52	8.59
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	13.53	0.20	0.18	0.12	0.07	0.20
EBIT Growth (%)	24.35	39.90	18.25	40.62	12.63	266.32
Net Profit Growth (%)	46.33	55.66	16.38	128.22	-32.88	1,368.29
EPS Growth (%)	46.43	0.55	0.15	1.23	-0.33	13.72
Book Value Growth (%)	11.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	19.56	49.42	71.79	53.60	95.62	58.66
Price / Book Value	2.80	5.89	6.11	4.43	3.80	3.67
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	14.50	29.99	36.53	27.22	27.40	27.22
Close Price ($)	42.68	95.35	89.32	57.81	46.27	42.48
High Price ($)	109.50	109.50	91.93	58.34	47.95	46.29
Low Price ($)	42.25	85.98	57.11	44.35	34.98	34.58
Market Cap ($ Cr)	68,041.33	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.43	0.51	0.51	0.49	0.53	0.57
Short term debt to equity ratio	0.07	0.02	0.08	0.03	0.00	0.02
Current Ratio	1.24	1.62	1.08	1.32	1.51	1.48
Quick Ratio	0.74	1.08	0.64	0.82	1.02	1.10
Interest Coverage	11.64	10.70	6.90	8.30	3.46	4.08

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	14.52	14.58	15.27	15.65	15.53	14.96
Asset Turnover	0.43	0.48	0.45	0.42	0.39	0.38
Receivable days	--	49.89	52.19	53.84	53.97	50.83
Inventory Days	--	168.92	149.20	146.90	127.82	122.15
Payable days	--	61.77	53.60	60.91	60.88	53.92
Cash Conversion Cycle	--	157.04	147.79	139.83	120.91	119.06

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)